Cite
HARVARD Citation
Kirschbaum, M. et al. (2018). A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. British journal of haematology. pp. 445-448. [Online].